Trials / Recruiting
RecruitingNCT06297993
Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)
A Global Multi-Center Prospective Observational Cohort to Support Drug Development in Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- PSC Partners Seeking a Cure · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Develop an appropriate real-world data comparator cohort to support the design, execution, and serve as an external control for interventional clinical trials in PSC.
Detailed description
Global, multi-center longitudinal observational cohort study. Collection of prospective clinical data to include liver-related clinical outcomes and safety events, hepatobiliary malignancies, relevant key biomarkers, imaging assessments, PSC-related clinical symptoms, patient-reported outcomes, and medication use in adult patients with PSC.
Conditions
Timeline
- Start date
- 2024-05-06
- Primary completion
- 2029-01-01
- Completion
- 2031-01-01
- First posted
- 2024-03-07
- Last updated
- 2026-02-19
Locations
16 sites across 5 countries: United States, Canada, Germany, Italy, New Zealand
Source: ClinicalTrials.gov record NCT06297993. Inclusion in this directory is not an endorsement.